These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28084586)

  • 21. Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.
    Tsai HC; Chang FP; Li TH; Liu CW; Huang CC; Huang SF; Yang YY; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Hou MC; Lin HC
    Biomed Res Int; 2019; 2019():6740616. PubMed ID: 31321239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive protein.
    Šilhavý J; Zídek V; Landa V; Šimáková M; Mlejnek P; Oliyarnyk O; Malínská H; Kazdová L; Mancini M; Pravenec M
    Physiol Res; 2015; 64(3):295-301. PubMed ID: 25536316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction.
    Park SY; Lee SW; Shin HK; Chung WT; Lee WS; Rhim BY; Hong KW; Kim CD
    Arthritis Rheum; 2010 Mar; 62(3):732-41. PubMed ID: 20131233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin Decreases Mean Platelet Volume in Patients With Diabetes Mellitus.
    Akyüz A; Akkoyun DÇ; Değirmenci H; Oran M
    Angiology; 2016 Feb; 67(2):116-20. PubMed ID: 25943745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease.
    Larkin BP; Nguyen LT; Hou M; Glastras SJ; Chen H; Faiz A; Chen J; Wang R; Pollock CA; Saad S
    Diabetes Obes Metab; 2022 Oct; 24(10):1939-1949. PubMed ID: 35635331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21?
    Morrison MC; Yakala GK; Liang W; Wielinga PY; Salic K; van Koppen A; Tomar T; Kleemann R; Heeringa P; Kooistra T
    Sci Rep; 2017 Jun; 7(1):2915. PubMed ID: 28588299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F; Li M; Cheng L; Zhang T; Hu J; Cao M; Zhao J; Guo R; Gao L; Zhang X
    Life Sci; 2008 Dec; 83(25-26):828-35. PubMed ID: 18983856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.
    Yen CH; Lin KC; Leu S; Sun CK; Chang LT; Chai HT; Chung SY; Chang HW; Ko SF; Chen YT; Yip HK
    Eur J Pharm Sci; 2012 Aug; 46(5):455-67. PubMed ID: 22484332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis.
    Chen Y; Pandiri I; Joe Y; Kim HJ; Kim SK; Park J; Ryu J; Cho GJ; Park JW; Ryter SW; Chung HT
    Oxid Med Cell Longev; 2016; 2016():3949813. PubMed ID: 27057275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
    Morsy MA; Heeba GH; Mahmoud ME
    Eur J Pharmacol; 2015 Mar; 750():90-7. PubMed ID: 25625658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of rosuvastatin in experimental renal failure rats via improved endothelial function.
    Liu YZ; Liu M; Zhang YM; Kang L; Chen PZ; Wang ZF; Feng Y; Zheng JH
    Biol Res Nurs; 2013 Jul; 15(3):356-64. PubMed ID: 22544519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis.
    Tanaka Y; Kume S; Araki S; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Sugimoto T; Koya D; Haneda M; Kashiwagi A; Maegawa H; Uzu T
    Kidney Int; 2011 Apr; 79(8):871-82. PubMed ID: 21270762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: is there a triangular relationship?
    Öner-İyidoğan Y; Tanrıkulu-Küçük S; Seyithanoğlu M; Koçak H; Doğru-Abbasoğlu S; Aydin AF; Beyhan-Özdaş Ş; Yapişlar H; Koçak-Toker N
    Can J Physiol Pharmacol; 2014 Oct; 92(10):805-12. PubMed ID: 25211173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.
    Lee WC; Chen HC; Wang CY; Lin PY; Ou TT; Chen CC; Wen MC; Wang J; Lee HJ
    Biosci Biotechnol Biochem; 2010; 74(7):1355-61. PubMed ID: 20622454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet.
    Reisin E; Ebenezer PJ; Liao J; Lee BS; Larroque M; Hu X; Aguilar EA; Morse SA; Francis J
    Am J Med Sci; 2009 Oct; 338(4):301-9. PubMed ID: 19826320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of metformin on renal injury of C57BL/6J mouse treated with high fat diet.
    Zhang SQ; Sun YT; Xu TH; Zhang XF; Liu YZ; Ma MJ; Wang LN; Yao L
    Pharmazie; 2014 Dec; 69(12):904-8. PubMed ID: 25951664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
    Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
    Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional changes in the kidneys of high-fat diet-induced obese mice.
    Deji N; Kume S; Araki S; Soumura M; Sugimoto T; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Koya D; Haneda M; Kashiwagi A; Uzu T
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F118-26. PubMed ID: 18971213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of the Anti-Inflammatory Effects of Four Combined Statin and Antiplatelet Therapies on Tumor Necrosis Factor-Mediated Acute Inflammation in vivo.
    Cho O; Kim HS; Park KY; Heo TH
    Pharmacology; 2019; 104(1-2):21-27. PubMed ID: 30970359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.